Arcosa Current Deferred Revenue from 2010 to 2026

ACA Stock  USD 127.84  0.33  0.26%   
Arcosa's Current Deferred Revenue is increasing over the years with stable fluctuation. Overall, Current Deferred Revenue is expected to go to about 121 M this year. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2018-12-31
Previous Quarter
58.4 M
Current Value
71.3 M
Quarterly Volatility
23 M
 
Covid
 
Interest Hikes
Check Arcosa financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcosa's main balance sheet or income statement drivers, such as Tax Provision of 35.9 M, Interest Income of 11.1 M or Depreciation And Amortization of 123.2 M, as well as many indicators such as Price To Sales Ratio of 0.9, Dividend Yield of 0.0038 or PTB Ratio of 0.98. Arcosa financial statements analysis is a perfect complement when working with Arcosa Valuation or Volatility modules.
  
Build AI portfolio with Arcosa Stock
Check out the analysis of Arcosa Correlation against competitors.
Analyzing Arcosa's Current Deferred Revenue over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Current Deferred Revenue has evolved provides context for assessing Arcosa's current valuation and future prospects.

Latest Arcosa's Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of Arcosa Inc over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Arcosa's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcosa's overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Pretty Stable
   Current Deferred Revenue   
       Timeline  

Arcosa Current Deferred Revenue Regression Statistics

Arithmetic Mean69,630,676
Geometric Mean64,101,377
Coefficient Of Variation37.62
Mean Deviation16,496,789
Median70,900,000
Standard Deviation26,191,909
Sample Variance686T
Range102.4M
R-Value0.18
Mean Square Error708.9T
R-Squared0.03
Significance0.50
Slope916,525
Total Sum of Squares10976.3T

Arcosa Current Deferred Revenue History

2026121 M
2025115.2 M
2024100.2 M
202334.5 M
202240.5 M
202118.6 M
202044.7 M

About Arcosa Financial Statements

Arcosa stakeholders use historical fundamental indicators, such as Arcosa's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Arcosa investors may analyze each financial statement separately, they are all interrelated. For example, changes in Arcosa's assets and liabilities are reflected in the revenues and expenses on Arcosa's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Arcosa Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue115.2 M121 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Arcosa Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcosa's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcosa Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcosa Inc Stock:
Is Construction & Engineering space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcosa. If investors know Arcosa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Arcosa assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
3.353
Dividend Share
0.2
Earnings Share
3.06
Revenue Per Share
58.022
Quarterly Revenue Growth
0.246
Understanding Arcosa Inc requires distinguishing between market price and book value, where the latter reflects Arcosa's accounting equity. The concept of intrinsic value - what Arcosa's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Arcosa's price substantially above or below its fundamental value.
Understanding that Arcosa's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Arcosa represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Arcosa's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.